Kawasaki disease (KD) shock syndrome (KDSS) is hypotension with KD. We compared children with KDSS and matched control children with KD. Children with KDSS more often were female, had a lower platelet count and sodium concentration, had a condition refractory to immunoglobulin, and had abnormal echocardiography results. KDSS is a unique subset of KD.
Kawasaki disease (KD) is an acute vasculitis characterized by ≥5 days of fever with conjunctival injection, rash, oral and distal extremity changes, and cervical lymphadenopathy.
Coronary artery abnormalities occur in approximately 25% of untreated patients [1] , but treatment with intravenous immunoglobulin (IVIg) and aspirin decreases the rate of cardiac sequelae to 2% to 4% [2] . The condition in approximately 10% to 20% of patients with KD fails to respond to initial IVIg therapy, and such patients have higher rates of coronary abnormality [3] .
A subset of patients with KD with hypotension (or KD shock syndrome [KDSS]) has been described; these patients have a higher incidence of IVIg resistance and significantly different demographics and laboratory and cardiac abnormalities than those of children with KD without shock [4] [5] [6] [7] [8] [9] . We sought to compare these features in patients with KDSS in a case-control study with time-matched control-patients with KD without hypotension.
METHODS

Study Design
At Ann & Robert H. Lurie Children's Hospital of Chicago, a tertiary care pediatric hospital, a pediatric infectious disease (PID) physician confirms and follows all KD diagnoses. Between 1999 and 2011, 756 children were diagnosed with KD. Those who required an intensive care unit (ICU) stay, fluid resuscitation, and/or vasoactive agents were identified prospectively.
Case-patients were hypotensive and diagnosed with complete (≥5 days of fever and ≥4 clinical criteria) or incomplete (≥5 days of fever, 2-3 clinical criteria, and supplemental laboratory criteria) KD [10] . Hypotension was defined as a systolic blood pressure of <70 mm Hg in children aged 1 to 12 months or <70 + (2 × age [in years]) mm Hg in children aged 1 to 12 years [11] . Inclusion hypotension measurements were obtained before or >8 hours after IVIG therapy was completed. Controlpatients had complete or incomplete KD without hypotension. Exclusion criteria were not meeting criteria for KD, having an alternate diagnosis, or hypotension only during IVIg administration (case-patients). Three control-patients were matched to each case-patient according to admission date (±28 days) to control for potential seasonal variation.
Data Collection
Medical records were accessed to obtain demographic, clinical, and laboratory data. The serum sodium concentration was determined before parenteral fluids were given. The echocardiographic data we obtained included mitral regurgitation (not including trace or trivial), pericardial effusion (not including trace or trivial), coronary artery enlargement (Z score > 2.5), and left ventricular dysfunction (LVD) (ejection fraction < 54% or shortening fraction < 28%). IVIg resistance was diagnosed by a PID physician and characterized by persistent or recurrent fever and/or clinical features ≥36 hours after IVIg therapy was completed. The Children's Memorial Research Center/Lurie Children's Hospital Institutional Review Board approved this study.
Statistical Analysis
Categorical and continuous variables are reported as number (percentage) and mean (standard deviation [SD]), respectively. Conditional logistic regression models were used when appropriate. To account for multiple comparisons in secondary analyses of echocardiographic findings and KDSS, a Bonferroniadjusted significance threshold (P = .01) was used. Otherwise, a P value of <.05 was considered significant. Analyses were performed using SAS 9.4 (SAS Institute, Cary, NC).
Sixteen (2.1%) of 756 children diagnosed with KD required ICU care, fluid resuscitation, and/or vasoactive agents. After retrospective review, 4 children were excluded for not meeting diagnostic criteria for KD or defined hypotension or having a subsequent alternate diagnosis. Therefore, 12 (1.6%) children with KDSS were included in this study.
Case-patients tended to be older and were more likely to be female (Table 1) . No racial/ethnic differences were noted. A majority of the patients had complete KD. Case-patients were more likely to have IVIg-refractory disease. For refractory cases, treatment regimens included 2 doses of IVIg, 2 doses of IVIg and pulse corticosteroids (3 days of intravenous methylprednisolone, 30 mg/kg per day), and 3 doses of IVIg and pulse corticosteroids. The day of illness on which the initial dose of IVIg was administered was not significantly different between case-patients and control-patients. Seven (58%) case-patients required ICU care and at least 1 vasoactive agent, including dobutamine, dopamine, epinephrine, or milrinone.
Case-patients had significantly lower initial platelet counts and higher C-reactive protein levels. Sodium data from 11 of 12 case-patients and 21 of 36 control-patients were available. The mean baseline sodium concentration was significantly lower in case-patients, and hyponatremia occurred in 10 (91%) of 11 case-patients and 7 (33%) of 21 control-patients (P < .003).
Other laboratory values were not significantly different between the 2 groups.
Echocardiography was performed in control-patients at diagnosis and 2 and 6 weeks after discharge and in case-patients at diagnosis and as necessitated by clinical status. At least 1 abnormality consistent with KD was present in 10 (83%) of 12 case-patients and 11 (31%) of 36 control-patients (P = .01). Pericardial effusion, LVD, and mitral regurgitation were present more often in case-patients than in control-patients ( Table 1) . The proportions of patients with coronary dilation were not significantly different between the 2 groups. All children with echocardiographic abnormalities related to KD experienced subsequent normalization.
DISCUSSION
The results of this study add to the limited literature on KDSS. Hypotension confounds the diagnosis because of overlapping signs and symptoms of KD, septic shock, and toxic shock syndrome. The precise mechanism of shock in patients with KDSS remains unclear. Our case-patients required a wide range of support, from volume resuscitation to administration of multiple vasopressors.
The demographics of our patients with KDSS are similar to those of previous studies, that is, a female predominance and a trend to older age (11 [89%] of 12 were >36 months old) were found [4, 6, 8] . Other studies did not reveal the same tendencies, likely because of small sample sizes and different populations. As in previous reports, KDSS was more likely to be IVIg resistant [4, 6] . Our data also corroborate previously recognized laboratory abnormalities in patients with KDSS, including lower platelet counts and higher C-reactive protein values [4, 6, 8] . It is interesting to note that our case-patients were not more likely to have coronary artery dilation, but they more commonly had other echocardiographic manifestations of acute KD, including pericardial effusion (odds ratio [OR], 6.01), LVD (OR, 21), and mitral regurgitation (OR, 10.4). Our study recognized the rarely reported finding of hyponatremia in patients with KDSS [9] . Although not listed as a supplemental diagnostic laboratory measurement, hyponatremia has been well described in patients with KD and has been identified as a risk factor for cardiac abnormalities [12] . Day of illness at presentation (mean ± SD) 5.6 ± 1.3 7.1 ± 2.7 .07
Day of illness at treatment (mean ± SD) 6.0 ± 1.6 7.4 ± 2.5 .08
Length of stay (mean ± SD) (days) 8.7 ± 3.7 3.3 ± 1. The pathophysiologic mechanisms of hyponatremia in patients with KDSS can include dehydration, a syndrome of inappropriate antidiuretic hormone secretion, and acute kidney injury. These etiologies were not evaluated fully in our patients. Hyponatremia can contribute to the presence of shock because of increased vascular leakage or poor cardiac function. Additional studies are needed to determine the mechanisms that contribute to shock and hyponatremia and the relationship between them.
Our study had strengths and limitations. PID physicians identified our case-patients prospectively. Because no definitive test for KD exists, it is possible that children who did not truly have KD were included. Some cases of KD and shock might have been missed. In some critically ill children, fluid resuscitation might have been administered before blood pressure was recorded. In addition, we defined shock as documented hypotension, which is a surrogate end point and late marker of shock. We could have missed children with early shock who received fluids before a hypotensive episode. We believe that our case-patients represent a small and unique KD subgroup, but we acknowledge that shock in KD might be more common than we identified. Last, sodium was checked less frequently in patients without shock, which might have contributed to an underestimation of hyponatremia in the control-patients.
The results of this study add to the limited data on an important subset of patients with KD and shock. Our data expand on the previously described characteristics of patients with KDSS, including hyponatremia. The mechanisms of hypotension and hyponatremia in patients with KD remain unclear and merit further investigation. Hyponatremia might provide clues to the mechanism of hypotension. Patients with KD with hypotension might require hemodynamic support and are at high risk for their disease to be IVIg refractory. KDSS, along with septic shock and toxic shock, should be included in the differential diagnosis of children who present with fever and hypotension.
